DK162054C - Cephalosporinsalte, fremgangsmaade til fremstilling deraf samt injicerbare praeparater indeholdende samme - Google Patents

Cephalosporinsalte, fremgangsmaade til fremstilling deraf samt injicerbare praeparater indeholdende samme

Info

Publication number
DK162054C
DK162054C DK020789A DK20789A DK162054C DK 162054 C DK162054 C DK 162054C DK 020789 A DK020789 A DK 020789A DK 20789 A DK20789 A DK 20789A DK 162054 C DK162054 C DK 162054C
Authority
DK
Denmark
Prior art keywords
preparing
procedure
same
preparations containing
injectable preparations
Prior art date
Application number
DK020789A
Other languages
Danish (da)
English (en)
Other versions
DK20789A (da
DK20789D0 (da
DK162054B (da
Inventor
Murray Arthur Kaplan
Thomas W Hudyma
Robert Alan Lipper
Kun Mao Shih
Susan D Boettger
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22510643&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK162054(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of DK20789D0 publication Critical patent/DK20789D0/da
Publication of DK20789A publication Critical patent/DK20789A/da
Publication of DK162054B publication Critical patent/DK162054B/da
Application granted granted Critical
Publication of DK162054C publication Critical patent/DK162054C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK020789A 1988-01-19 1989-01-18 Cephalosporinsalte, fremgangsmaade til fremstilling deraf samt injicerbare praeparater indeholdende samme DK162054C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/144,899 US4910301A (en) 1985-08-05 1988-01-19 Cefepime cephalosporin salts
US14489988 1988-01-19

Publications (4)

Publication Number Publication Date
DK20789D0 DK20789D0 (da) 1989-01-18
DK20789A DK20789A (da) 1989-07-20
DK162054B DK162054B (da) 1991-09-09
DK162054C true DK162054C (da) 1992-02-10

Family

ID=22510643

Family Applications (1)

Application Number Title Priority Date Filing Date
DK020789A DK162054C (da) 1988-01-19 1989-01-18 Cephalosporinsalte, fremgangsmaade til fremstilling deraf samt injicerbare praeparater indeholdende samme

Country Status (32)

Country Link
US (1) US4910301A (fr)
JP (1) JPH0725768B2 (fr)
KR (1) KR950003612B1 (fr)
AT (1) AT399878B (fr)
AU (1) AU615509B2 (fr)
BE (1) BE1002749A5 (fr)
CA (1) CA1298288C (fr)
CY (1) CY1663A (fr)
CZ (1) CZ281602B6 (fr)
DD (2) DD283397A5 (fr)
DE (1) DE3901359A1 (fr)
DK (1) DK162054C (fr)
EG (1) EG18749A (fr)
ES (1) ES2012948A6 (fr)
FI (1) FI86854C (fr)
FR (1) FR2626003B1 (fr)
GB (1) GB2213819B (fr)
GR (1) GR1001218B (fr)
HK (1) HK72292A (fr)
HU (1) HU205940B (fr)
IE (1) IE67447B1 (fr)
IT (1) IT1229528B (fr)
LU (1) LU87432A1 (fr)
NL (1) NL192266C (fr)
NZ (1) NZ227605A (fr)
OA (1) OA09227A (fr)
PT (1) PT89474B (fr)
SE (1) SE505258C2 (fr)
SG (1) SG75492G (fr)
SK (1) SK281768B6 (fr)
YU (1) YU221188A (fr)
ZA (1) ZA89407B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
DE68917574T2 (de) * 1988-12-27 1994-12-15 Chugai Pharmaceutical Co Ltd Reinigungsverfahren für 1,2-Bis(nicotinamido)propan.
CA2011116C (fr) * 1989-03-06 1999-11-16 Murray A. Kaplan Dihydrochlorure de bmy-28142 lyophilise pour usage parenteral
DE3919259A1 (de) * 1989-06-13 1990-12-20 Hoechst Ag Kristalline cephem-saeureadditionssalze und verfahren zu ihrer herstellung
MY108872A (en) * 1991-09-10 1996-11-30 Bristol Myers Squibb Co Preparation of a cephalosporin antibiotic using the syn-isomer of a thiazolyl intermediate.
US5594129A (en) * 1991-09-10 1997-01-14 Bristol-Myers Squibb Company Process for the preparation of a cephalosporin antibiotic
YU81692A (sh) * 1991-09-10 1995-03-27 Bristol-Myers Co. Postupak za proizvodnju cefalosporinskog antibiotika
US5698703A (en) * 1991-09-10 1997-12-16 Bristol-Myers Squibb Company Syn-isomer of thiazolyl intermediate and process for the preparation thereof
CA2099692C (fr) * 1992-07-24 2003-09-30 Gary M. F. Lim Procede de preparation d'intermediaires de la cephalosporine
US5401842A (en) * 1992-09-08 1995-03-28 Bristol-Myers Squibb Company Injectable compositions of a cephalosporin dihydrate salt
CA2101571A1 (fr) * 1992-09-08 1994-03-09 Elizabeth A. Garofalo Dihydrate cristallise d'un sel de cephalosporine dihydrate; compositions injectables a base de ce compose
US5391729A (en) * 1992-09-08 1995-02-21 Bristol-Myers Squibb Company Crystalline dihydrate of a cephalosporin salt
JPH0840907A (ja) 1994-08-03 1996-02-13 Meiji Seika Kaisha Ltd セファロスポリン注射剤
WO2005094800A2 (fr) * 2004-03-31 2005-10-13 Lupin Ltd. Composition de cefepime co-precipite et procede de preparation correspondant
WO2006008749A1 (fr) * 2004-07-16 2006-01-26 Hetero Drugs Limited Procede de preparation d'intermediaires de cephalosporine pures
ITMI20051684A1 (it) * 2005-09-13 2007-03-14 Harvest Lodge Ltd Procedimento per la produzione del dicloridrato di amminoacidi
ITMI20060422A1 (it) * 2006-03-09 2007-09-10 Harvest Lodge Ltd Procedimento diretto per la produzione del dicloridrato di un amminoacido
US8151846B2 (en) * 2006-12-15 2012-04-10 Center Line Wheel Corporation Wheel having inner bead-lock
AR077320A1 (es) * 2009-07-20 2011-08-17 Intervet Int Bv Metodo para la preparacion de particulas de cefquinoma y formulaciones farmaceuticas que las comprenden.
CN103304580B (zh) * 2013-06-09 2014-07-09 四川省惠达药业有限公司 一种盐酸头孢吡肟化合物、其制备方法及其药物组合物
AU2016367284C1 (en) * 2015-12-10 2018-09-20 Naeja-Rgm Pharmaceuticals Ulc Cephem compounds, their production and use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029655A (en) * 1975-04-11 1977-06-14 Eli Lilly And Company Method of preparing stable sterile crystalline cephalosporins for parenteral administration
JPS55151588A (en) * 1979-05-14 1980-11-26 Takeda Chem Ind Ltd Preparation of cephalosporin salt crystal
GB2052490B (en) * 1979-05-25 1983-09-07 Glaxo Group Ltd Intermediates for use in the preparation of cephalosporin antibiotics
US4329453A (en) * 1979-10-02 1982-05-11 Glaxo Group Limited Cephalosporin antibiotic
CA1213882A (fr) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporines
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
US4537959A (en) * 1984-03-26 1985-08-27 Eli Lilly And Company Crystalline cephalosporin antibiotic salt
US4751295A (en) * 1984-04-09 1988-06-14 Bristol-Myers Company Cephalosporin derivatives
US4749694A (en) * 1984-04-26 1988-06-07 Merck & Co., Inc. Novel lysine esters used as absorption
FR2585705B1 (fr) * 1985-08-05 1989-01-13 Bristol Myers Co Sels de cephalosporine et compositions injectables
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
US4791196A (en) * 1986-09-26 1988-12-13 Sankyo Company Limited Crystalline cephem carboxylic acid addition salt

Also Published As

Publication number Publication date
DE3901359A1 (de) 1989-10-05
ATA8589A (de) 1994-12-15
GB2213819A (en) 1989-08-23
HK72292A (en) 1992-10-02
JPH0725768B2 (ja) 1995-03-22
SE505258C2 (sv) 1997-07-21
FI86854C (fi) 1992-10-26
SG75492G (en) 1992-10-02
OA09227A (fr) 1992-06-30
JPH029885A (ja) 1990-01-12
FI86854B (fi) 1992-07-15
FI890213A0 (fi) 1989-01-16
IT8947539A0 (it) 1988-01-17
CA1298288C (fr) 1992-03-31
FR2626003B1 (fr) 1992-10-16
GR1001218B (el) 1993-06-21
GB2213819B (en) 1991-11-27
SK24389A3 (en) 2000-12-11
SE8900173D0 (sv) 1989-01-18
NL8900111A (nl) 1989-08-16
SK281768B6 (sk) 2001-07-10
CZ24389A3 (en) 1996-08-14
KR950003612B1 (ko) 1995-04-17
FI890213A (fi) 1989-07-20
ZA89407B (en) 1989-09-27
DK20789A (da) 1989-07-20
BE1002749A5 (fr) 1991-05-28
AT399878B (de) 1995-08-25
SE8900173L (en) 1989-01-18
HU205940B (en) 1992-07-28
EG18749A (en) 1993-12-30
DE3901359C2 (fr) 1992-04-30
PT89474A (pt) 1990-02-08
NL192266B (nl) 1996-12-02
HUT50347A (en) 1990-01-29
YU221188A (en) 1990-04-30
FR2626003A1 (fr) 1989-07-21
DD284807A5 (de) 1990-11-28
NZ227605A (en) 1991-06-25
GB8901073D0 (en) 1989-03-15
DK20789D0 (da) 1989-01-18
IT1229528B (it) 1991-09-04
LU87432A1 (fr) 1989-08-30
NL192266C (nl) 1997-04-03
CZ281602B6 (cs) 1996-11-13
IE890144L (en) 1989-07-19
KR890011895A (ko) 1989-08-23
AU2862389A (en) 1989-07-20
IE67447B1 (en) 1996-04-03
DK162054B (da) 1991-09-09
DD283397A5 (de) 1990-10-10
US4910301A (en) 1990-03-20
PT89474B (pt) 1993-12-31
CY1663A (en) 1993-05-14
ES2012948A6 (es) 1990-04-16
AU615509B2 (en) 1991-10-03

Similar Documents

Publication Publication Date Title
DK654589D0 (da) Heterocykliske derivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne
DK162054C (da) Cephalosporinsalte, fremgangsmaade til fremstilling deraf samt injicerbare praeparater indeholdende samme
DK147488A (da) Benzoxazolderivat samt fremgangsmaade til fremstilling deraf
DK165249C (da) Imidazooe4,5-baaquinolin-2-thionderivater samt fremgangsmaade til fremstilling deraf
DK316189D0 (da) Heteroaryloxy-n-isopropylanilider, fremgangsmaade til deres fremstilling samt deres anvendelse
DK163991C (da) Dichloranilinderivater, fremgangsmaade til fremstilling af disse, samt farmaceutiske praeparater indeholdende derivaterne
DK219387A (da) Aminothiazol- og aminooxazolderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK161327C (da) Substituerede 2-piperazinopteridiner, fremgangsmaade til fremstilling deraf samt laegemidler indeholdende forbindelserne
DK642588A (da) Indanderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK592189A (da) Nitroimidazoler, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK346889A (da) Heteropolysaccharid bm07, fremgangsmaade til fremstilling deraf samt anvendelse deraf
DK486789A (da) Benzoxazolinonderivater, fremgangsmaader til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK13089A (da) Substituerede 5,6,7,8-tetrahydro-4h-thieno-(2,3-d)azepin-forbindelser, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK469189D0 (da) Substituerede thienopyraner, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
NO890330L (no) Fremgangsmaate til fremstilling av forbindelser med psykotrop virkning.
DK178589A (da) Triazoloaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK553689D0 (da) Phenyloxypropanolaminderivater, fremgangsmaade til fremstilling af saadanne forbindelser samt laegemiddel indeholdende disse
DK614589A (da) Imidazolholdige peptider samt fremgangsmaade til fremstilling deraf
DK231089A (da) Substituerede azolthioethere, fremgangsmaade til fremstilling deraf samt deres anvendelse som skadedyrsbekaempelsesmiddel
DK404587A (da) 5-deoxy-5-flourkanamycin b-derivater samt fremgangsmaader til fremstilling deraf
DK259089A (da) Aminoguanidinoaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK146389A (da) (1,3-dioxolan-4-ylmethylthio)phenyl)carbamater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK354789A (da) Alkenyltetrazolderivater samt fremgangsmaade til fremstilling deraf
DK378989D0 (da) Halogenvinylazolderivater, fremgangsmaader til deres fremstilling samt deres anvendelse
DK165293C (da) Quinoxalinforbindelser, fremgangsmaade til fremstilling deraf, samt farmaceutiske praeparater indeholdende forbindelserne

Legal Events

Date Code Title Description
PUP Patent expired